<html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:m="http://www.w3.org/1998/Math/MathML" xmlns:svg="http://www.w3.org/2000/svg" lang="en" xml:lang="en">
<head>
<title>Chapter 23 Assessment in Chapter 23 Cancer Genetics</title>
<meta charset="utf-8"/>
<meta content="final" name="process"/>
<meta content="3.1" name="schema"/>
<link href="../styles/pie_9781319216801.css" rel="stylesheet" type="text/css"/>
<meta content="urn:uuid:1df703a4-880e-4fb4-a16f-bd0ab0744194" name="Adept.expected.resource"/>
</head>
<body class="bodymatter" epub:type="bodymatter">
<section class="end-of-section" id="ben_9781319297145_baBjDf04I2">
<header id="ben_9781319297145_aoXojQzaUT"><h2 class="title" epub:type="title" id="ben_9781319297145_GpdPGJzMwE"><span aria-label="727" epub:type="pagebreak" id="page727" role="doc-pagebreak" title="727"/>Chapter 23 Assessment</h2></header>
<section class="learning-resources v1" epub:type="learning-resources" id="ben_9781319297145_3qYvE4eQJc">
<header id="ben_9781319297145_6a8WxH6ad1"><h3 class="title cap v1" epub:type="title" id="ben_9781319297145_soXNClwmdu">Comprehension questions</h3></header>
<section class="subsect1" id="ben_9781319297145_gO8Eyk02jO">
<header id="ben_9781319297145_bi0hm6RQSy"><h4 class="level1" id="ben_9781319297145_cY84Mf2LsT">Section 23.1</h4></header>
<ol class="numbered-list" id="ben_9781319297145_8sdPwSB3YN">
<li class="question noindent" epub:type="question" id="ben_9781319297145_gDrYpJXf06">What types of evidence indicate that cancer arises from genetic changes?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_3f3eRSfErT">How is cancer different from most other types of genetic diseases?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_RO9ZgjELl4">Outline Knudsonâ€™s two-hit hypothesis of retinoblastoma, and describe how it helps to explain unilateral and bilateral cases of retinoblastoma.</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_5nsFR86KeD">Briefly explain how cancer progresses through clonal evolution.</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_RnkWpsYzxd">
<header id="ben_9781319297145_cwcEv231hG"><h4 class="level1" id="ben_9781319297145_EMuwBgmYWi">Section 23.2</h4></header>
<ol class="numbered-list" id="ben_9781319297145_l5ZoB44Nao" start="5">
<li class="question noindent" epub:type="question" id="ben_9781319297145_UFOHr8LoJp">What is the difference between an oncogene and a tumor-suppressor gene? Give some examples of the functions of proto-oncogenes and tumor-suppressor genes in normal cells.</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_EE27yEtnVJ">What is haploinsufficiency? How might it affect cancer risk?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_FzdOsH7oC1">How do cyclins and CDKs differ? How do they interact in controlling the cell cycle?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_xQqtlzymF3">Briefly outline the events that control the progression of cells through the G<sub class="semantic-sub" id="ben_9781319297145_4yP6dgCrpw">1</sub>/S checkpoint in the cell cycle.</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_bgs1iU1zPj">Briefly outline the events that control the progression of cells through the G<sub class="semantic-sub" id="ben_9781319297145_AWlhsoN9my">2</sub>/M checkpoint in the cell cycle.</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_GGiseGkGaL">What is a signal-transduction pathway? Why are mutations in components of signal-transduction pathways often associated with cancer?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_FfyFqQYZK0">How is the Ras protein activated and inactivated?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_7y6V2IN7ep">Why do mutations in genes that encode DNA-repair enzymes often produce a predisposition to cancer?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_23Frq4yAnc">What role do telomeres and telomerase play in cancer progression?</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_aVZEeVYfrb">
<header id="ben_9781319297145_0oYV1HaWZ6"><h4 class="level1" id="ben_9781319297145_tN2lic9HPW">Section 23.3</h4></header>
<ol class="numbered-list" id="ben_9781319297145_SXc8qM92hG" start="14">
<li class="question noindent" epub:type="question" id="ben_9781319297145_k7gCYeEk0i">How is an epigenetic change different from a mutation?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_tbaRjXsdVC">How is DNA methylation related to cancer?</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_lQ05SCMp4O">
<header id="ben_9781319297145_7IfSmV7ZWE"><h4 class="level1" id="ben_9781319297145_7ph62gnVp3">Section 23.4</h4></header>
<ol class="numbered-list" id="ben_9781319297145_UwGfV3HLkW" start="16">
<li class="question noindent" epub:type="question" id="ben_9781319297145_1OPLLlwR5X">Briefly outline some of the genetic changes commonly associated with the progression of colorectal cancer.</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_p2RR4w9tCb">
<header id="ben_9781319297145_PrAAubCAxS"><h4 class="level1" id="ben_9781319297145_NWfAcS96Vh">Section 23.5</h4></header>
<ol class="numbered-list" id="ben_9781319297145_k5q1dreoKY" start="17">
<li class="question noindent" epub:type="question" id="ben_9781319297145_uOIIGaOPQ9"><a class="crossref" href="pie_9781319216801_BM_answer.xhtml#ben_9781319297145_wOsQaYN9JE" id="ben_9781319297145_jvUMK3nRfL">*</a>Explain how chromosome deletions, inversions, and translocations can cause cancer.</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_WD8VqkB8XD">Briefly outline how the Philadelphia chromosome leads to chronic myelogenous leukemia.</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_xNp8YzN6uB">What is genomic instability? Give some ways in which genomic instability may arise.</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_DUPlyoKdRJ">
<header id="ben_9781319297145_EXIyCrfnRV"><h4 class="level1" id="ben_9781319297145_9grNc5FloL">Section 23.6</h4></header>
<ol class="numbered-list" id="ben_9781319297145_QQXeHCnnWC" start="20">
<li class="question noindent" epub:type="question" id="ben_9781319297145_9XQNy9Fr66"><a class="crossref" href="pie_9781319216801_BM_answer.xhtml#ben_9781319297145_dyvGUOP49Y" id="ben_9781319297145_TZP82X2BI2">*</a>How do viruses contribute to cancer?</li>
</ol>
</section>
</section>
<section class="learning-resources v1" epub:type="learning-resources" id="ben_9781319297145_iZoGtoz4qz">
<header id="ben_9781319297145_Ds0PmLZePC"><h3 class="title cap v1" epub:type="title" id="ben_9781319297145_0OORrqBoMk"><span aria-label="728" epub:type="pagebreak" id="page728" role="doc-pagebreak" title="728"/>Application questions and problems</h3></header>
<section class="subsect1" id="ben_9781319297145_9mfuTK8JUK">
<header id="ben_9781319297145_aaA630zzmQ"><h4 class="level1" id="ben_9781319297145_xomFC4K7OC">Introduction</h4></header>
<ol class="numbered-list" id="ben_9781319297145_nKRG0RN6wb" start="21">
<li class="question noindent" epub:type="question" id="ben_9781319297145_cPUE2pOio0">
<div class="group v5" id="ben_9781319297145_rBCvmlz9rp">
<img alt="" aria-hidden="true" class="decorative size-med inline" id="ben_9781319297145_zBuRXZStGL" role="presentation" src="../images/piercegenetics7e_01_PG_18e.png"/> What characteristics of the pedigrees shown in <strong class="important" id="ben_9781319297145_N2DKdh4hcM"><a class="crossref" href="pie_9781319216801_ch23_01.xhtml#ben_9781319297145_QSHS0baxXg" id="ben_9781319297145_P2ioLlIWTe">Figure 23.1</a></strong> suggest that Li-Fraumeni syndrome is inherited as an autosomal dominant trait? (See <a class="crossref" href="pie_9781319216801_ch06_01.xhtml#ben_9781319297145_TnCspasvqI" id="ben_9781319297145_RdfHbaUChD">Chapter 6</a> for a review of pedigrees.)
</div></li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_6UbdNYysSE">
<header id="ben_9781319297145_RSxe97TGGb"><h4 class="level1" id="ben_9781319297145_Rw91u9nw8C">Section 23.1</h4></header>
<ol class="numbered-list" id="ben_9781319297145_W1z8gvqFam" start="22">
<li class="question noindent" epub:type="question" id="ben_9781319297145_nQEPXygA7E">If cancer is fundamentally a genetic disease, how might an environmental factor such as smoking cause cancer?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_ROwGmakKje"><a class="crossref" href="pie_9781319216801_BM_answer.xhtml#ben_9781319297145_E5Yiev6umx" id="ben_9781319297145_aBTPipSYye">*</a>Both genes and environmental factors contribute to cancer. Prostate cancer is 39 times more common among people from Utah than among people from Shanghai (see <strong class="important" id="ben_9781319297145_hO6ToAsUEv"><a class="crossref" href="pie_9781319216801_ch23_02.xhtml#ben_9781319297145_LRSN8QVhsz" id="ben_9781319297145_tnY4lI5tmG">Table 23.2</a></strong>). Briefly outline how you might determine whether these differences in the incidence of prostate cancer are due to differences in the genetic makeup of the two populations or to differences in their environments.</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_KfWwMlwp77">
<header id="ben_9781319297145_gRCtWDhcSl"><h4 class="level1" id="ben_9781319297145_hZGnlndp39">Section 23.2</h4></header>
<ol class="numbered-list" id="ben_9781319297145_UZcs3BsaHC" start="24">
<li class="question noindent" epub:type="question" id="ben_9781319297145_EDn6Pbk5Hi"><a class="crossref" href="pie_9781319216801_BM_answer.xhtml#ben_9781319297145_ibIDCBRu1w" id="ben_9781319297145_1sbAYk98LY">*</a>The <i class="semantic-i" id="ben_9781319297145_IHVxNQfKZV">TP53</i> gene, which plays a role in Li-Fraumeni syndrome and in many types of cancer (see the introduction to this chapter), is said to be a tumor-suppressor gene. Which of its characteristics suggest that it is a tumor-suppressor gene, rather than an oncogene?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_LH5Phec98J">Mutations in the <i class="semantic-i" id="ben_9781319297145_DHhlI1ob3j">RB</i> gene are often associated with cancer. Explain how a mutation that results in a nonfunctional RB protein contributes to cancer.</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_1TZjuwiqTy">Cells in a tumor contain mutated copies of a particular gene that promotes tumor growth. Gene therapy (see <a class="crossref" href="pie_9781319216801_ch19_01.xhtml#ben_9781319297145_LOQ40viYWJ" id="ben_9781319297145_vaGl7TXVSk">Chapter 19</a>) can be used to introduce a normal copy of this gene into the tumor cells. Would you expect this therapy to be effective if the mutated gene were an oncogene? A tumor-suppressor gene? Explain your reasoning.</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_IAzBVAZ9pl">What would be the effect on the cell cycle of a drug that inhibited each of the following?
<ol class="ol-alpha-lc" id="ben_9781319297145_1DggtrimUl">
<li id="ben_9781319297145_vmQaN2BvOo">MPF</li>
<li id="ben_9781319297145_E2Sja1UXXu">Cyclin-Eâ€“CDK</li>
<li id="ben_9781319297145_6IA76suZsf">Cyclin-Dâ€“CDK</li>
</ol></li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_baB7oWjZns">What would be the effect of a drug that inhibited the breakdown of cyclin B?</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_z4UAgzkwF2">
<header id="ben_9781319297145_6UY0OmliDV"><h4 class="level1" id="ben_9781319297145_8bD8N41lvO">Section 23.3</h4></header>
<ol class="numbered-list" id="ben_9781319297145_hua4vCoAr7" start="29">
<li class="question noindent" epub:type="question" id="ben_9781319297145_HxUZJRLaTB">
<div class="group v5" id="ben_9781319297145_bBW1UX0lnM">
<img alt="" aria-hidden="true" class="decorative size-med inline" id="ben_9781319297145_7zBrkbjt5M" role="presentation" src="../images/piercegenetics7e_01_PG_18e.png"/> <img alt="" aria-hidden="true" class="decorative size-med inline" id="ben_9781319297145_ykr5NaRdZv" role="presentation" src="../images/piercegenetics7e_03_pg74.png"/> David Seligson and his colleagues examined epigenetic modifications (see <a class="crossref" href="pie_9781319216801_ch21_01.xhtml#ben_9781319297145_N6Oqsjd4iX" id="ben_9781319297145_Sq2ucg8IK7">Chapter 21</a>) associated with prostate cancer. They measured levels of histone protein modification in prostate tumors and their association with clinical outcomes (D. B. Seligson et al. 2005. <i class="semantic-i" id="ben_9781319297145_bCNezIw3e7">Nature</i> 435:1262â€“1266). They used antibodies to stain for acetylation at three different sites, and for methylation at two different sites, on histone proteins. They found that the degree of histone acetylation and methylation helped predict whether prostate cancer would return within 10 years in the patients who had a prostate tumor removed. Explain how acetylation and methylation might be associated with tumor recurrence in prostate cancer. (Hint: See <a class="crossref" href="pie_9781319216801_ch17_01.xhtml#ben_9781319297145_5lnSPYWvZw" id="ben_9781319297145_7RFGCqKqOj">Chapter 17</a>.)
</div></li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_GmWruh7HOE">
<div class="group v5" id="ben_9781319297145_Dbjxaw7M6F">
<img alt="" aria-hidden="true" class="decorative size-med inline" id="ben_9781319297145_eoysYAlVrl" role="presentation" src="../images/piercegenetics7e_01_PG_18e.png"/> Some cancers have been treated with drugs that demethylate DNA (see <a class="crossref" href="pie_9781319216801_ch17_03.xhtml#ben_9781319297145_hCZ8eGlZbe" id="ben_9781319297145_5iu01ogVkS">Section 17.2</a>). Explain how these drugs might work. Do you think the cancer-causing genes that responded to the demethylation are likely to have been oncogenes or tumor-suppressor genes? Explain your reasoning.
</div></li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_boOa4v8I6G">
<header id="ben_9781319297145_TxUIFSo43t"><h4 class="level1" id="ben_9781319297145_wLP28UhT5l">Section 23.5</h4></header>
<ol class="numbered-list" id="ben_9781319297145_PM1O3p9YX2" start="31">
<li class="question noindent" epub:type="question" id="ben_9781319297145_2cok28XlUJ"><a class="crossref" href="pie_9781319216801_BM_answer.xhtml#ben_9781319297145_7d45ZPX7xc" id="ben_9781319297145_AMsqVZ8mBJ">*</a>Some cancers are consistently associated with the deletion of a particular part of a chromosome. Does the deleted region contain an oncogene or a tumor-suppressor gene? Explain.</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_OOclqH6GfP">
<header id="ben_9781319297145_iZGA1TX5zA"><h4 class="level1" id="ben_9781319297145_xwyWkDTasE">Section 23.6</h4></header>
<ol class="numbered-list" id="ben_9781319297145_RnWOONADtV" start="32">
<li class="question noindent" epub:type="question" id="ben_9781319297145_BRFF0bGrZC">Assume that the provirus in <strong class="important" id="ben_9781319297145_CDmAMRQPAn"><a class="crossref" href="pie_9781319216801_ch23_07.xhtml#ben_9781319297145_yaEoPNo2DW" id="ben_9781319297145_nvNbyvCrlO">Figure 23.14</a></strong> inserts just upstream of a tumor-suppressor gene. Would this insertion be likely to cause cancer? Why or why not?</li>
</ol>
</section>
</section>
<section class="learning-resources v1" epub:type="learning-resources" id="ben_9781319297145_SUbeyfqtvJ">
<header id="ben_9781319297145_x1LpBNAWCw"><h3 class="title cap v1" epub:type="title" id="ben_9781319297145_xlCG8GD4H5">Challenge questions</h3></header>
<section class="subsect1" id="ben_9781319297145_8OGLji2HC7">
<header id="ben_9781319297145_1WTrqVjY9k"><h4 class="level1" id="ben_9781319297145_ugpoQ7R4Gs">Section 23.2</h4></header>
<ol class="numbered-list" id="ben_9781319297145_bVl0ajVAFT" start="33">
<li class="question noindent" epub:type="question" id="ben_9781319297145_ltU55a1KQM">Many cancer cells are immortal (will divide indefinitely) because they have mutations that allow telomerase to be expressed. How might this knowledge be used to design anticancer drugs?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_WfvXasZRuM">
<div class="group v5" id="ben_9781319297145_0xBJvGbtRH">
<img alt="" aria-hidden="true" class="decorative size-med inline" id="ben_9781319297145_zjSPyBWUTg" role="presentation" src="../images/piercegenetics7e_01_PG_18e.png"/> Bloom syndrome is an autosomal recessive disease that exhibits haploinsufficiency. A recent survey showed that people heterozygous for mutations at the <i class="semantic-i" id="ben_9781319297145_FHOt5vZYpi">BLM</i> locus are at increased risk of colon cancer. Suppose you are a genetic counselor (see <a class="crossref" href="pie_9781319216801_ch06_01.xhtml#ben_9781319297145_TnCspasvqI" id="ben_9781319297145_TDFttnrK9Z">Chapter 6</a>). A young woman is referred to you whose mother has Bloom syndrome; the young womanâ€™s father has no family history of Bloom syndrome. The young woman asks whether she is likely to experience any other health problems associated with her family history of Bloom syndrome. What advice would you give her?
</div></li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_z7tJMdXgY9">Imagine that you discover a large family in which bladder cancer is inherited as an autosomal dominant trait. Briefly outline a series of studies that you might conduct to identify the gene that causes bladder cancer in this family.</li>
</ol>
</section>
</section>
<section class="learning-resources v1" epub:type="learning-resources" id="ben_9781319297145_5EyOGSjHeA">
<header id="ben_9781319297145_gMD9nwdZVL"><h3 class="title cap v5" epub:type="title" id="ben_9781319297145_JMkug7OEgr"><span aria-label="729" epub:type="pagebreak" id="page729" role="doc-pagebreak" title="729"/><img alt="" aria-hidden="true" class="decorative size-large inline" id="ben_9781319297145_8jAPMPFrma" role="presentation" src="../images/SpeechBub_People_01.png"/> Active learning: think-pair-share questions</h3></header>
<section class="subsect1" id="ben_9781319297145_Ek58im4UWQ">
<header id="ben_9781319297145_AxUN0TTE78"><h4 class="level1" id="ben_9781319297145_Ee0m2xMnW7">Section 23.1</h4></header>
<ol class="numbered-list" id="ben_9781319297145_qmclGZgMLt">
<li class="question noindent" epub:type="question" id="ben_9781319297145_Dui0raYnpt">The risk of dying from various cancers often differs between males and females. For example, the risk of a male dying from bladder cancer is 1 in 106, but the risk for a female is only 1 in 294. Why are rates of death from cancer different in men and women? Provide some possible explanations.</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_vBTN50TjGl">A couple has one child with bilateral retinoblastoma. The mother is free from cancer, but the father has unilateral retinoblastoma, and he has a brother who has bilateral retinoblastoma.
<ol class="ol-alpha-lc" id="ben_9781319297145_agxo0NU9GA">
<li id="ben_9781319297145_cHse4KvAur">If the couple has another child, what is the probability that this next child will have retinoblastoma?</li>
<li id="ben_9781319297145_9Yx3co2ZPg">If the next child has retinoblastoma, is it likely to be bilateral or unilateral?</li>
<li id="ben_9781319297145_FxF0TXwtzd">Explain why the fatherâ€™s case of retinoblastoma is unilateral, whereas his childâ€™s and brotherâ€™s cases are bilateral.</li>
</ol></li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_PogpQnJfiV"><strong class="important" id="ben_9781319297145_4ToOLLi4Lb"><a class="crossref" href="pie_9781319216801_ch23_02.xhtml#ben_9781319297145_hgW7iM0cEU" id="ben_9781319297145_lvT0vfC2VH">Table 23.3</a></strong> lists occupation as an environmental factor associated with cancer. What occupations do you think might be associated with higher rates of cancer? What about these occupations might create higher cancer rates?</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_NBAQckiIMo">
<header id="ben_9781319297145_fnguLmJqOH"><h4 class="level1" id="ben_9781319297145_f2hYsT4Ptb">Section 23.2</h4></header>
<ol class="numbered-list" id="ben_9781319297145_lgUbH2S7c1" start="4">
<li class="question noindent" epub:type="question" id="ben_9781319297145_39SXvxOZPJ">Drivers are mutations that drive the cancer process; passengers are mutations that arise randomly in the process of tumor development and do not contribute to the progression of cancer. How might researchers go about distinguishing between drivers and passengers? Propose some different approaches.</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_5LNN1lTbYS">
<header id="ben_9781319297145_P2OaDz3Fni"><h4 class="level1" id="ben_9781319297145_3cOmeGJU3u">Section 23.6</h4></header>
<ol class="numbered-list" id="ben_9781319297145_EFAkG93GJV" start="5">
<li class="question noindent" epub:type="question" id="ben_9781319297145_IhJTLAUhTw">In 2007, then Texas governor Rick Perry became the first governor in the United States to mandate by executive order the vaccination of all Texas girls aged 11â€“12 for HPV, arguing that the vaccine prevented cancer. Some conservatives criticized Perry, arguing that the vaccine would encourage sexual promiscuity among children and young adults. The Texas legislature overturned the executive order, and Perry later reversed his position, saying the order was a mistake. Do you think states should require boys and girls to be vaccinated for HPV? Discuss reasons for and against such a requirement.</li>
</ol>
</section>
</section>
<section class="learning-resources v1" epub:type="learning-resources" id="ben_9781319297145_4Jc6ftx09V">
<header id="ben_9781319297145_byI3NK2343"><h3 class="title cap v1" epub:type="title" id="ben_9781319297145_6Xv19m2vbd"><img alt="" aria-hidden="true" class="decorative size-med inline" id="ben_9781319297145_l2B70v24FM" role="presentation" src="../images/piercegenetics7e_01_PG_17.png"/> Active learning: concept mapping exercises</h3></header>
<section class="subsect1" id="ben_9781319297145_cC6ojJ8fFB">
<header id="ben_9781319297145_8qNp0HNKwt"><h4 class="level1" id="ben_9781319297145_0Cpw9JxbCS">Introduction</h4></header>
<ol class="numbered-list" id="ben_9781319297145_hxYRr4qHiZ">
<li class="question noindent" epub:type="question" id="ben_9781319297145_Nnp9FvPMGT">Create a concept map that outlines the role of the <i class="semantic-i" id="ben_9781319297145_iS7LlaMaO9">TP53</i> gene and p53 protein in Li-Fraumeni syndrome. Include at least the following terms and phrases in your map: Li-Fraumeni syndrome, predisposition to cancer, autosomal dominant trait, <i class="semantic-i" id="ben_9781319297145_MxdnTa1vxw">TP53</i> gene, p53 protein, tumor-suppressor gene, cell cycle, genome stability, apoptosis, retrotransposition.</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_QF26gdMQqe">
<header id="ben_9781319297145_uk4j9Z0M6R"><h4 class="level1" id="ben_9781319297145_RQsINPJBP5">Section 23.1</h4></header>
<ol class="numbered-list" id="ben_9781319297145_3TOKDcqB5H" start="2">
<li class="question noindent" epub:type="question" id="ben_9781319297145_Xvj9f13tNu">Summarize the process by which normal cells become cancerous by creating a concept map that links the following terms: normal cells, clonal evolution, tumor, malignant tumor, metastasis.</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_KOYgezMTT0">
<header id="ben_9781319297145_3KAVLa6Tgx"><h4 class="level1" id="ben_9781319297145_8YhYtV6T3l">Section 23.2</h4></header>
<ol class="numbered-list" id="ben_9781319297145_mQoVUOu76D" start="3">
<li class="question noindent" epub:type="question" id="ben_9781319297145_Z6iFeMvXYE">Draw a concept map that summarizes the differences between oncogenes and tumor-suppressor genes. Include at least 9 concepts in your map.</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_vJNQVl7AnS">
<header id="ben_9781319297145_2tp7dNWfAx"><h4 class="level1" id="ben_9781319297145_gznc7Bgbkg">Section 23.4</h4></header>
<ol class="numbered-list" id="ben_9781319297145_0IuZqdC7z9" start="4">
<li class="question noindent" epub:type="question" id="ben_9781319297145_gujNa5hK10">With a concept map, summarize the stages in the progression of a normal colon cell to metastatic cancer, including some of the important genes involved in this process. You should include at least 10 concepts or terms in your map.</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_qQX1YvWbiT">
<header id="ben_9781319297145_FwQHsTz0hA"><h4 class="level1" id="ben_9781319297145_Kpf1QlP9BB">Section 23.5</h4></header>
<ol class="numbered-list" id="ben_9781319297145_U5JTqKl3Bu" start="5">
<li class="question noindent" epub:type="question" id="ben_9781319297145_Q1of3kdcVR">Using a concept map, outline the different ways that change in chromosome number or structure can lead to cancer. Include the following terms or phrases in your map: chromosome changes, change in chromosome structure, aneuploidy, genomic instability, genes involved in cell cycle control, deletions, inversions, translocations, loss of tumor-suppressor genes, chromosome breaks, fusion proteins, disruption of tumor-suppressor genes, stimulation of oncogenes.</li>
</ol>
</section>
<aside aria-label="learning-resources" class="learning-resources c3 main-flow v1" epub:type="learning-resources" id="ben_9781319297145_6R31PBavKc" title="learning-resources">
<p class="noindent" id="ben_9781319297145_gn9gz9mwQi"><span aria-label="730" epub:type="pagebreak" id="page730" role="doc-pagebreak" title="730"/><img alt="" aria-hidden="true" class="decorative size-med inline" id="ben_9781319297145_76YmjjAAy6" role="presentation" src="../images/piercegenetics7e_03_pg80.png"/> Self-study tools that will help you practice what youâ€™ve learned and reinforce this chapterâ€™s concepts are available online. Go to <a class="external" href="http://www.saplinglearning.com" id="ben_9781319297145_HcNk5DBiDp">www.saplinglearning.com</a>.</p>
</aside>
</section>
</section>
</body>
</html>